Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of Somatropin in Adult GHD
NCT01698944Phase 4Terminated
- Sponsor
- Novo Nordisk
- Start
- May 2001
- Primary completion
- Nov 2002
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in adult growth hormone deficiency (AGHD), sponsored by Novo Nordisk. Started May 2001; status: terminated.
02
Drugs
somatropin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT01698944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698944.